AIM
SNY icon

Acrospire Investment Management’s Sanofi SNY Stock Holding History

Acrospire Investment Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-393
Closed -$19K – 1220
2017
Q2 		$19K Sell
393
-400
-50% -$19.1K 0.02% 1556
2017
Q1 		$36K Sell
793
-1,200
-60% -$50.9K 0.03% 1227
2016
Q4 		$81K Buy
+1,993
New +$78.5K 0.03% 1074

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acrospire Investment Management's SNY Position: Q3 2017 in Review

Acrospire Investment Management sold out of Sanofi (SNY) in Q3 2017, closing a stake of 393 shares — an estimated $19K sold.

Acrospire Investment Management first reported a position in SNY in Q4 2016 and held it in 3 quarters. The position peaked at $81K in Q4 2016. 485 funds tracked by Wall St. Rank hold SNY as of Q3 2017.

  • Acrospire Investment Management reported no remaining Sanofi position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 393 Sanofi shares in Q3 2017, an estimated $19K.
  • Acrospire Investment Management first reported a position in Sanofi in Q4 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Sanofi position peaked at $81K in Q4 2016.
  • 485 funds tracked by Wall St. Rank held Sanofi as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.